LATEST ALERTS
Philip Morris International (PMI) reports an overall positive performance in 2022, boosted by growth in its Iqos business, with revenues and shipment volumes slightly up for the year
Philip Morris International (PMI)’s decision to go ahead with the purchase of all offered Swedish Match shares, despite falling short of its 90% target, means it may run the business as if it owned all of it
Philip Morris International (PMI) has confirmed that it will go ahead and accept all Swedish Match shares that have been tendered to it despite not achieving its 90% minimum stake threshold
EU antitrust regulators have conditionally approved the takeover of Swedish nicotine pouch specialist Swedish Match by the tobacco giant Philip Morris International (PMI) for an estimated €16bn
Swedish Match has reported an 18% sales increase in the first nine months of the year, boosted by the smoke-free product segment. The company saw a continued impressive performance in the US market, where Zyn shipment volumes grew by nearly 40%
Philip Morris International (PMI) has raised its public offer for its European rival Swedish Match from SEK106 ($9.52) to a final price of SEK116 ($10.42) per share in a bid to finalise its takeover
Philip Morris International (PMI) reported strong third quarter results in terms of revenue but saw a number of setbacks in shipment volumes as it looks to meet its goal of becoming a majority smoke-free company by 2025
Dryft, which contends it was forced to sell out of the US nicotine pouch market because of alleged frivolous lawsuits from major nicotine pouch producer Swedish Match, may have an edge in the upcoming court case on the matter
This report covers the US role as a modern oral tobacco product player, examining snus, tobacco-free nicotine pouches and all-free products
Swedish Match’s sales of smoke-free products boomed in the first quarter of 2020, with the segment recording a 35% year-on-year increase to SEK2.508bn (€234m)
The US International Trade Commission (USITC) is looking into a possible infringement of the patent for a nicotine pouch product, following a claim led by Swedish Match North America
Swedish Match is to increase production of its tobacco-free nicotine pouch ZYN to 200m cans a year after a steep rise in demand in the US
The US Food and Drug Administration (FDA) has granted its first modified risk order for eight snus smokeless tobacco products to be sold with certain modified risk claims by Swedish Match USA
The US Food and Drug Administration (FDA) has grated its first ever modified risk orders to eight snus products from Swedish Match, which can now be advertised as less harmful than traditional cigarettes
The European Court of Justice (ECJ) has upheld the ban on the sale of snus which has applied since 1992 in the whole EU except Sweden, which was granted an exemption under the 2014 Tobacco Products Directive (TPD)
The US Food and Drug Administration (FDA) will have to consider again next year the possibility that snus could be a reduced-risk form of tobacco, following a series of applications from R.J. Reynolds Tobacco Company
The New Nicotine Alliance is to join an attempt by manufacturer Swedish Match to overturn the UK’s snus ban. If successful, the bid could lead to the smokeless tobacco product being legalised throughout the EU
Swedish Match has at last obtained some answers from the U.S. Food and Drug Administration (FDA) on its attempt to have snus smokeless tobacco products classified as modified risk
Swedish Match is contesting the European Union’s ban on snus in court
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
